BrightView vs Toro
BV and TTC side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BV and TTC compare
Toro is the larger company, worth 11 times as much as BrightView ($10.2B against $914M).
Toro grew revenue faster over the last twelve months (5.2% versus 1.5% for BrightView).
Toro keeps more of each dollar of sales as profit, with a net margin of 7.6% compared with 0.04% at BrightView.
Toro pays a dividend yielding 1.5%; BrightView does not pay one.
Toro scores higher on the StockData Score (16 against 5 for BrightView), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BV | TTC |
|---|---|---|
| Size and price | ||
| Market cap | $914M | $10.2B |
| Share price | $9.87 | $107.28 |
| Change, 1 year | −16.9% | 48.6% |
| Change, 5 years | −36.0% | 2.6% |
| Beta (5Y) | 1.05 | 0.97 |
| Employees | 18K | – |
| StockData Score | ||
| Total score | 5 | 16 (better) |
| Valuation score | 1 | 1 |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 3 | 4 (better) |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | – | 28.7× |
| P/S | 0.3× (better) | 2.1× |
| P/B | 0.7× (better) | 7.6× |
| EV/EBITDA | 24.1× | 17.2× (better) |
| P/FCF | – | 14.3× |
| FCF yield | −4.4% | 7.0% (better) |
| Fair value | $3.59 | $93.39 |
| Margin of safety | −175% | −14.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 1.5% | 5.2% (better) |
| Revenue growth, 5Y average | 1.2% | 5.9% (better) |
| Net income growth (TTM) | −98.2% | 9.1% (better) |
| EPS growth (TTM) | −385% | 13.3% (better) |
| EPS growth, 5Y average | – | 0.91% |
| Profitability | ||
| Gross margin | 20.4% | 33.4% (better) |
| Operating margin | 2.8% | 10.3% (better) |
| Net margin | 0.04% | 7.6% (better) |
| FCF margin | −1.5% | 15.0% (better) |
| Return on equity | 0.08% | 26.4% (better) |
| Return on invested capital | 1.8% | 17.6% (better) |
| Financial health | ||
| Debt / equity | 0.72 | 0.72 (better) |
| Net debt / EBITDA | 11.84 | 1.24 (better) |
| Interest coverage | 1.4× | 8.7× (better) |
| Current ratio | 1.29 | 1.58 (better) |
| Altman Z-score | 1.23 | 5.31 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 1.5% |
| Payout ratio | – | 41.3% |
| Years of dividend growth | – | 16 |
| Dividend growth, 5Y average | – | 8.7% |
| Buyback yield | 6.1% (better) | 3.5% |
| Shareholder yield | 6.1% (better) | 5.0% |
| Ownership | ||
| Held by institutions | 103% | 94.3% |
| Held by insiders | 26.2% | 0.39% |
| Insider net buying, 12 months | $316K (better) | −$14.2M |
| Short interest, % of float | 6.1% | 3.9% |
Go deeper
- BV stock overview
- BV income statement
- BV valuation and score
- TTC stock overview
- TTC income statement
- TTC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.